155 related articles for article (PubMed ID: 37682272)
21. Influence of cellular ERalpha/ERbeta ratio on the ERalpha-agonist induced proliferation of human T47D breast cancer cells.
Sotoca AM; van den Berg H; Vervoort J; van der Saag P; Ström A; Gustafsson JA; Rietjens I; Murk AJ
Toxicol Sci; 2008 Oct; 105(2):303-11. PubMed ID: 18644836
[TBL] [Abstract][Full Text] [Related]
22. Estrogen receptor β selective agonists reduce invasiveness of triple-negative breast cancer cells.
Hinsche O; Girgert R; Emons G; Gründker C
Int J Oncol; 2015 Feb; 46(2):878-84. PubMed ID: 25420519
[TBL] [Abstract][Full Text] [Related]
23. ERbeta in breast cancer--onlooker, passive player, or active protector?
Fox EM; Davis RJ; Shupnik MA
Steroids; 2008 Oct; 73(11):1039-51. PubMed ID: 18501937
[TBL] [Abstract][Full Text] [Related]
24. Study of ER, PR, HER2/neu, p53, and Ki67 expression in primary breast carcinomas and synchronous metastatic axillary lymph nodes.
Khande TA; Joshi AR; Khandeparkar SGS; Kulkarni MM; Gogate BP; Kakade AR; Sahu PD; Khillare CD
Indian J Cancer; 2020; 57(2):190-197. PubMed ID: 32445323
[TBL] [Abstract][Full Text] [Related]
25. Artemisinin selectively decreases functional levels of estrogen receptor-alpha and ablates estrogen-induced proliferation in human breast cancer cells.
Sundar SN; Marconett CN; Doan VB; Willoughby JA; Firestone GL
Carcinogenesis; 2008 Dec; 29(12):2252-8. PubMed ID: 18784357
[TBL] [Abstract][Full Text] [Related]
26. Nutraceuticals known to promote hair growth do not interfere with the inhibitory action of tamoxifen in MCF7, T47D and BT483 breast cancer cell lines.
Baker R; Dell'Acqua G; Richards A; Thornton MJ
PLoS One; 2024; 19(2):e0297080. PubMed ID: 38408073
[TBL] [Abstract][Full Text] [Related]
27. Steroid receptors, HER2/neu and Ki-67, in endometrioid type of endometrial carcinoma: Correlation with conventional histomorphological features of prognosis.
Chakravarty D; Gupta N; Goda JS; Srinivasan R; Patel FD; Dhaliwal L
Acta Histochem; 2010 Jul; 112(4):355-63. PubMed ID: 19446313
[TBL] [Abstract][Full Text] [Related]
28. Expression of estrogen receptor beta in the breast carcinoma of BRCA1 mutation carriers.
Litwiniuk MM; Roznowski K; Filas V; Godlewski DD; Stawicka M; Kaleta R; Breborowicz J
BMC Cancer; 2008 Apr; 8():100. PubMed ID: 18405391
[TBL] [Abstract][Full Text] [Related]
29. Expression of the insulin-like growth factor-I receptor in primary breast cancer and lymph node metastases: correlations with estrogen receptors alpha and beta.
Koda M; Sulkowski S; Garofalo C; Kanczuga-Koda L; Sulkowska M; Surmacz E
Horm Metab Res; 2003; 35(11-12):794-801. PubMed ID: 14710360
[TBL] [Abstract][Full Text] [Related]
30. Identification of estrogen receptor dimer selective ligands reveals growth-inhibitory effects on cells that co-express ERα and ERβ.
Powell E; Shanle E; Brinkman A; Li J; Keles S; Wisinski KB; Huang W; Xu W
PLoS One; 2012; 7(2):e30993. PubMed ID: 22347418
[TBL] [Abstract][Full Text] [Related]
31. Direct regulation of microRNA biogenesis and expression by estrogen receptor beta in hormone-responsive breast cancer.
Paris O; Ferraro L; Grober OM; Ravo M; De Filippo MR; Giurato G; Nassa G; Tarallo R; Cantarella C; Rizzo F; Di Benedetto A; Mottolese M; Benes V; Ambrosino C; Nola E; Weisz A
Oncogene; 2012 Sep; 31(38):4196-206. PubMed ID: 22231442
[TBL] [Abstract][Full Text] [Related]
32. Sex steroid receptors in rheumatoid arthritis.
Ishizuka M; Hatori M; Suzuki T; Miki Y; Darnel AD; Tazawa C; Sawai T; Uzuki M; Tanaka Y; Kokubun S; Sasano H
Clin Sci (Lond); 2004 Mar; 106(3):293-300. PubMed ID: 14570589
[TBL] [Abstract][Full Text] [Related]
33. ERα and ERβ co-expression: An indicator of aggressive tumors and hormonal sensitivity.
Oueslati M; Bittaieb I; Sassi N; Jemaa AB; Gamoudi A; Rahal K; Oueslati R
Oncol Lett; 2017 Aug; 14(2):1675-1682. PubMed ID: 28808484
[TBL] [Abstract][Full Text] [Related]
34. Estrogen Receptor-β Modulation of the ERα-p53 Loop Regulating Gene Expression, Proliferation, and Apoptosis in Breast Cancer.
Lu W; Katzenellenbogen BS
Horm Cancer; 2017 Aug; 8(4):230-242. PubMed ID: 28577282
[TBL] [Abstract][Full Text] [Related]
35. Clinical association of progesterone receptor isoform A with breast cancer metastasis consistent with its unique mechanistic role in preclinical models.
Rosati R; Oppat K; Huang Y; Kim S; Ratnam M
BMC Cancer; 2020 Jun; 20(1):512. PubMed ID: 32493230
[TBL] [Abstract][Full Text] [Related]
36. ERα and ERβ Homodimers in the Same Cellular Context Regulate Distinct Transcriptomes and Functions.
Song D; He H; Indukuri R; Huang Z; Stepanauskaite L; Sinha I; Haldosén LA; Zhao C; Williams C
Front Endocrinol (Lausanne); 2022; 13():930227. PubMed ID: 35872983
[TBL] [Abstract][Full Text] [Related]
37. Estrogen receptor alpha-negative and progesterone receptor-positive breast cancer: lab error or real entity?
Kiani J; Khan A; Khawar H; Shuaib F; Pervez S
Pathol Oncol Res; 2006; 12(4):223-7. PubMed ID: 17189985
[TBL] [Abstract][Full Text] [Related]
38. Receptor conversion in distant breast cancer metastases.
Hoefnagel LD; van de Vijver MJ; van Slooten HJ; Wesseling P; Wesseling J; Westenend PJ; Bart J; Seldenrijk CA; Nagtegaal ID; Oudejans J; van der Valk P; van der Groep P; de Vries EG; van der Wall E; van Diest PJ
Breast Cancer Res; 2010; 12(5):R75. PubMed ID: 20863372
[TBL] [Abstract][Full Text] [Related]
39. A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells.
Williams C; Edvardsson K; Lewandowski SA; Ström A; Gustafsson JA
Oncogene; 2008 Feb; 27(7):1019-32. PubMed ID: 17700529
[TBL] [Abstract][Full Text] [Related]
40. Estrogen receptor alpha/beta isoforms, but not betacx, modulate unique patterns of gene expression and cell proliferation in Hs578T cells.
Secreto FJ; Monroe DG; Dutta S; Ingle JN; Spelsberg TC
J Cell Biochem; 2007 Aug; 101(5):1125-47. PubMed ID: 17520659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
